Cytosponge™
Cytosponge™ is a medical device with 9 clinical trials. Historical success rate of 71.4%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
62.5%
5 of 8 finished
37.5%
3 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Rapid Assessment of Esophageal Adenocarcinoma Risk Test
Cytosponge in Surveillance After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma
Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus
Cytosponge and Dietary Therapy in EoE
Cytosponge™ for Post-Chemoradiation Surveillance of Oesophageal Cancer
Clinical Trials (9)
Rapid Assessment of Esophageal Adenocarcinoma Risk Test
Cytosponge in Surveillance After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma
Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus
Cytosponge and Dietary Therapy in EoE
Cytosponge™ for Post-Chemoradiation Surveillance of Oesophageal Cancer
Cytosponge Protocol IRB 11-006429
Cytosponge™ Feasibility Study in Tanzania
Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative Therapy
Short Duration 6Fed Sponge For EoE Patients
All 9 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 9